A CTLA4high genotype is associated with myasthenia gravis in thymoma patients-Reference-Cited by-同舟云学术

A CTLA4high genotype is associated with myasthenia gravis in thymoma patients

Published:2005 Issue:4 Volume:58 Page:644-648
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Chuang Wen-Yu,Ströbel Philipp,Gold Ralf,Nix Wilfred,Schalke Berthold,Kiefer Reinhard,Opitz Andreas,Klinker Erdwine,Müller-Hermelink Hans K.,Marx Alexander

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference20 articles.

1. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

2. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry

3. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis

4. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosiso

5. Association of the CT60 marker of theCTLA4gene with systemic lupus erythematosus

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients;Molecular Neurobiology;2024-04-23

2. Prognosis of immune checkpoint inhibitor-induced myasthenia gravis: a single center experience and systematic review;Frontiers in Neurology;2024-04-03

3. Novel uses of complement inhibitors in myasthenia gravis—Two case reports;Muscle & Nerve;2024-01-11

4. Paraneoplastic autoimmune neurologic disorders associated with thymoma;Handbook of Clinical Neurology;2024

5. Impact of the cytotoxic T-lymphocyte associated antigen-4 rs231775 A/G polymorphism on cancer risk;Heliyon;2023-12